IPHA · Innate Pharma S.A.

Summary

Innate Pharma S.A. announced its Annual General Meeting of shareholders will be held on May 21, 2026, in Marseille, France, with registration and voting requirements, live webcast access, and a laboratory tour for registered shareholders.

Key takeaways

• AGM scheduled for May 21, 2026, at Innate Pharma’s headquarters in Marseille — sets timing for shareholder governance actions.
• Shareholders must register shares by May 14, 2026 (five trading days prior) to attend — affects eligibility for participation and voting rights.
• Bearer shareholders require an 'attestation de participation' from their broker to vote — introduces procedural step for certain holders.
• Written questions must be submitted by May 15, 2026 — establishes deadline for formal shareholder engagement ahead of the meeting.
• AGM documents are available via the Investors section of Innate Pharma’s website and upon email request — ensures regulatory compliance with French Commercial Code Article R. 225-83.